Skip to Content

Melexis Shares Offer Attractive 40% Upside; Decreasing Our Fair Value Estimate to EUR 100

Technology Sector artwork
Securities In This Article
Melexis NV
(MELE)

We believe narrow-moat Melexis MELE shares offer an attractive buying opportunity at this point. Although we are decreasing our fair value estimate to EUR 100 from EUR 105 after adjusting our medium-term forecasts, shares offer 40% upside for long-term investors who are willing to endure a few quarters of uncertainty. Melexis is trading at 13.0 times the 2022 EBIT and 11.3 times the last 12 months’ EBIT.

Shares are down 30% since Aug. 1 and down 15% in the past three weeks, in line with other analogue semiconductor companies as the market is anticipating a potential cycle change. Another reason for the selloff might be a read-through from recent Onsemi earnings. Shares of Onsemi sold off by 20% on Oct. 27 due to weak guidance for the fourth quarter, including mid-single-digit sequential revenue declines in automotive. However, we have also seen positive comments from other automotive chip companies, with STMicroelectronics and Infineon Technologies confirming double-digit growth for 2024 even after flat car production. During its Oct. 25 earnings call, Melexis management confirmed that its automotive supply/demand balance remains healthy for now.

We believe Melexis shares are especially attractive to buy during cyclical downturns. Melexis experiences the “bullwhip effect”—when there are swings in end-market auto demand the effect is more pronounced when a company is in the upper part of the supply chain, which is where Melexis is. After cyclical contractions, a cyclical upswing happens and sales and profits rebound strongly. Melexis has an almost debt-free balance sheet, allowing it to comfortably steer its way through cycle troughs

Our forecast assumes a high-single-digit revenue CAGR over the next decade and 24%-27% EBIT margins as chip content per car keeps growing. We also assume a double-digit cyclical sales decline in 2025 with a strong recovery in 2026 and 2027. Shares were up 7% on Nov. 2, in line with other semiconductor stocks that have oversold recently.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Javier Correonero

Equity Analyst
More from Author

Javier Correonero is an equity analyst for Morningstar Holland BV, a wholly owned subsidiary of Morningstar, Inc. He covers European technology and telecommunications companies.

Before joining Morningstar in 2019, Correonero worked for almost two years as a valuation advisory analyst at Duff & Phelps (Kroll), where he was involved in valuation projects, purchase price allocations, and fairness opinions for different industries and companies.

Correonero holds a bachelor's degree in electromechanical engineering from Universidad Pontificia Comillas ICAI and master's degrees in management finance and industrial engineering from Politecnico di Milano and ICAI, respectively. He is fluent in English, Spanish, and Italian.

Sponsor Center